Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MGC Pharmaceuticals

MGC Pharmaceuticals?uq=UG6efJS6
2015 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
MXC STOCK SYMBOL
2 INVESTMENTS
$0.05 SHARE PRICE (As of Thursday Closing)
Description

Manufacturer of cannabis based pharmaceuticals created to treat previously unmet medical needs and improve the lives of patients. The company's products include active pharmaceutical ingredients, botanic products and dermatological products, in addition, it cultivates cannabis crops, enabling patients to cure their diseases.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
ASX
Primary Office
  • PO Box 1976
  • Perth, Western Australia 6872
  • Australia

+61 (08) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MGC Pharmaceuticals’s full profile, request a free trial.

MGC Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.03 - $0.10 $61.2M $0.05 4.38M 1.2B

MGC Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
FY 2016
30-Jun-2016
Enterprise Value 53,172 53,172 29,705 24,673
Revenue 91
EBITDA (6,425) (4,440)
Net Income (6,137) (4,485)
Total Assets 15,999 12,218
Total Debt 16 818
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MGC Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MGC Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

MGC Pharmaceuticals Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000 07-Feb-2017 000000000000000000 00.00 Other Pharmaceuticals and Biotechnology 00000 00000
Erin Mineral Resources 31-May-2012 Merger/Acquisition Gold Mining
To view this company’s complete investment and acquisition history, request access »

MGC Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000000 00000 31-May-2012 000000000000000000 Completed
  • 000 00000000000000
To view this company’s complete exits history, request access »

MGC Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MGC Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

MGC Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Roby Zomer Co-Founder, Chief Executive Officer & Executive Director
Nativ Segev Managing Director & Co-Founder